链霉菌来源的苯并异色烷醌家族抗生素的生物合成

Biosynthesis of benzoisochromanequinones antibiotics from streptomycetes——A review

苯并异色烷醌(benzoisochromanequinones,BIQs)家族抗生素是由链霉菌产生的聚酮类抗生素,其芳香聚酮母核结构中含有并联的两个芳香环和一个吡喃环,具有抗菌、抗肿瘤等多种生物学活性。BIQ抗生素聚酮链的早期生物合成过程代表了芳香聚酮抗生素母核的典型合成机制,而不同的后期修饰则决定了它们结构和生物学活性的多样性。在过去的二十几年中,以放线紫红素和美达霉素为研究重点,BIQ家族抗生素的生物合成机制逐渐得到揭示,但在后期结构修饰方面仍有许多问题有待解决。本文对BIQ家族抗生素的生物合成机制研究进行了综述,比较了不同BIQ家族抗生素结构特点、生物学活性,并重点阐述了它们生物合成中的后期结构修饰和调控过程的研究进展,并对BIQ抗生素在代谢工程方面的研究进行了展望。

Benzoisochromanequinones antibiotics,a group of bioactive polyketide compounds with aromatic polyketide skeletal cores,are accumulated in streptomycetes.The biosynthesis of benzoisochromanequinones antibiotics has triggered great interest because they not only represent model biosynthetic mechanisms of aromatic polyketide skeletal structures,but also possess a variety of tailoring modifications rendering them highly structural and bioactive diversity.Here we reviewed important advances in biosynthesis of benzoisochromanequinones antibiotics in recent 25 years with focusing on the modification mechanisms of these compounds and on the prospects of the metabolic engineering and pharmaceutical discovery of benzoisochromanequinones antibiotics.